Genomic analysis of cancer tissue reveals that somatic mutations commonly occur in a specific motif

Somatic mutations are hallmarks of cancer progression. We sequenced 26 matched human prostate tumor and constitutional DNA samples for somatic alterations in the SRD5A2, HPRT, and HSD3B2 genes, and identified 71 nucleotide substitutions. Of these substitutions, 79% (56/71) occur within a WKVnRRRnVWK...

Full description

Saved in:
Bibliographic Details
Published inHuman mutation Vol. 30; no. 1; pp. 39 - 48
Main Authors Makridakis, Nick M, Caldas Ferraz, Lúcio Fábio, Reichardt, Juergen K.V
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Somatic mutations are hallmarks of cancer progression. We sequenced 26 matched human prostate tumor and constitutional DNA samples for somatic alterations in the SRD5A2, HPRT, and HSD3B2 genes, and identified 71 nucleotide substitutions. Of these substitutions, 79% (56/71) occur within a WKVnRRRnVWK sequence (a novel motif we call THEMIS [from the ancient Greek goddess of prophecy]: W=A/T, K=G/T, V=G/A/C, R=purine (A/G), and n=any nucleotide), with one mismatch allowed. Literature searches identified this motif with one mismatch allowed in 66% (37/56) of the somatic prostate cancer mutations and in 74% (90/122) of the somatic breast cancer mutations found in all human genes analyzed. We also found the THEMIS motif with one allowed mismatch in 88% (23/26) of the ras1 gene somatic mutations formed in the sensitive to skin carcinogenesis (SENCAR) mouse model, after induction of error-prone DNA repair following mutagenic treatment. The high prevalence of the motif in each of the above mentioned cases cannot be explained by chance (P<0.046). We further identified 27 somatic mutations in the error-prone DNA polymerase genes pol η, pol κ, and pol β in these prostate cancer patients. The data suggest that most somatic nucleotide substitutions in human cancer may occur in sites that conform to the THEMIS motif. These mutations may be caused by "mutator" mutations in error-prone DNA polymerase genes. Hum Mutat 0, 1-10, 2008.
Bibliography:http://dx.doi.org/10.1002/humu.20810
Current affiliation for Nick M. Makridakis: Tulane Cancer Center, Tulane University, New Orleans, Louisiana.
Current affiliation for Lúcio Fábio Caldas Ferraz: Centro de Biologia Molecular e Engenharia Genética, University of Campinas, São Paulo, Brazil.
Communicated by David E. Goldgar
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Current address: Tulane Cancer Center, Tulane University, 1430 Tulane Avenue, SL-68, □New Orleans, LA 70112.
Current address: Centro de Biologia Molecular e Engenharia Genética, University of Campinas, São Paulo, Brazil.
ISSN:1059-7794
1098-1004
DOI:10.1002/humu.20810